Dr. Radhakrishnan Ramchandren, MD
Hematology (Hematology (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 102
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology (Internal Medicine) Physician primary
PA license MD425046 -
Hematology & Oncology Physician
MI license 4301085844 -
Independent Medical Examiner Physician
MI license 4301085844 -
Internal Medicine Physician
MI license 4301085844
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Reading Hospital West Reading, PA
Medical groups
- Reading Hospital (186 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 102
- Services billed
- 230
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 346 | 101 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 147 | 28 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 55 | 39 |
| New patient office or other outpatient visit, 60-74 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in West Reading, PA | 32 |
| Lenalidomide | 25 |
| Dexamethasone Other prescribers in West Reading, PA | 19 |
| Imbruvica (ibrutinib) | 19 |
| Imatinib Mesylate | 14 |
| Revlimid (lenalidomide) | 12 |
| Ondansetron Hcl Other prescribers in West Reading, PA | 11 |
| Valacyclovir (valacyclovir hcl) Other prescribers in West Reading, PA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 35 payments worth $40,237 in total to this clinician.
| GlaxoSmithKline, LLC. | $34,237 |
|---|---|
| Beigene USA, Inc. | $6,000 |
| Compensation for services other than consulting (speaking, faculty) | $26,175 |
|---|---|
| Travel and Lodging | $7,197 |
| Consulting Fee | $6,000 |
| Food and Beverage | $865 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Beigene USA, Inc. Jan 14, 2025 | Consulting Fee TEVIMBRA · Oncology | $6,000 |
| GlaxoSmithKline, LLC. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Lynchburg, VA · in-kind | $1,708 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,600 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Cherry Hill, NJ · in-kind | $1,272 |
| GlaxoSmithKline, LLC. Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,200 |
All 23 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| GlaxoSmithKline, LLC. Dec 4, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $675 |
| GlaxoSmithKline, LLC. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $475 |
| GlaxoSmithKline, LLC. Oct 9, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Philadelphia, PA · in-kind | $933 |
| GlaxoSmithKline, LLC. Oct 6, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $398 |
| GlaxoSmithKline, LLC. Oct 6, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $31.41 |
| GlaxoSmithKline, LLC. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $5,700 |
| GlaxoSmithKline, LLC. Sep 10, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Lynchburg, VA | $45.00 |
| GlaxoSmithKline, LLC. Aug 25, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Center Valley, PA | $421 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $3,800 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Lynchburg, VA · in-kind | $1,708 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Lynchburg, VA · in-kind | $149 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Apr 22, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Chicago, IL | $213 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,600 |
| GlaxoSmithKline, LLC. Mar 21, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Chicago, IL · in-kind | $708 |
| GlaxoSmithKline, LLC. Mar 21, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Chicago, IL · in-kind | $314 |
| GlaxoSmithKline, LLC. Mar 14, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Cherry Hill, NJ | $52.00 |
| GlaxoSmithKline, LLC. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $4,800 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Cherry Hill, NJ · in-kind | $1,272 |
| GlaxoSmithKline, LLC. Feb 25, 2025 | Travel and Lodging OJJAARA · ONCOLOGY · travel to Cherry Hill, NJ · in-kind | $278 |
| Beigene USA, Inc. Jan 14, 2025 | Consulting Fee TEVIMBRA · Oncology | $6,000 |
| GlaxoSmithKline, LLC. Jan 3, 2025 | Compensation for services other than consulting (speaking, faculty) OJJAARA · ONCOLOGY | $1,200 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,700 in research payments for these studies, mostly to the institutions running them.
- Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma
Beone Medicines Ltd. · Completed · NCT04318080
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.